Meeting
2021 ASCO Annual Meeting
Camrelizumab plus chemotherapy as neoadjuvant therapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, open-label, single-arm, phase 2 study.
Authors
Jingpei Li
Department of Thoracic Surgery/Esophageal Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Jingpei Li , Jun Liu , Zhuoyi Li , Fei Cui , Yuan Zeng , Wenhua Liang , Hengrui Liang , Wei Wang , Ke Xu , Weipeng Cai , JunHui Fu , Jianxing He
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
NCT04225364
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4028)
DOI
10.1200/JCO.2021.39.15_suppl.4028
Abstract #
4028
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial.
First Author: Jing Chen
Poster
2014 Gastrointestinal Cancers Symposium
A phase II study of weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC).
First Author: Fan Yun
Poster
2023 ASCO Annual Meeting
Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study.
First Author: Renquan Zhang
Poster
2023 ASCO Annual Meeting
Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial.
First Author: Lei Gong